Patents by Inventor Jingmiao SHI

Jingmiao SHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230322769
    Abstract: A heteroaromatic ring compound as a RET kinase inhibitor, and the preparation and the use thereof, wherein the compound is a compound having the structure of formula (I) or a pharmaceutically acceptable salt thereof. The compound or a salt thereof can be used for treating or preventing diseases or conditions by targeting receptors of fused and mutated forms of the RET gene, can effectively inhibit the growth of multiple tumor cells, produces an inhibitory effect on a RET gene fusion mutation and other proteases, and can be used for preparing an anti-tumor drug.
    Type: Application
    Filed: August 19, 2021
    Publication date: October 12, 2023
    Applicant: JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD.
    Inventors: Yongqiang ZHU, Zhaogang LIU, Chao FENG, Hao CHEN, Kaikai XU, Jia WANG, Jingmiao SHI
  • Patent number: 10654851
    Abstract: A type of deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereof. The derivatives are compounds of Formula (I) or pharmaceutically acceptable salts thereof. These compounds or salts thereof can be used for treatment or prevention of diseases or illnesses through certain mutant forms of epidermal growth factor receptors, inhibit the growth of various tumor cells effectively, and inhibit other proteases of EGFR and Her families, they can be used for preparing anti-tumor drugs.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: May 19, 2020
    Assignee: NANJING CHUANGTE PHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Yongqiang Zhu, Zhaogang Liu, Chao Feng, Shihe Hu, Hao Chen, Enhe Bai, Jie Wang, Jingmiao Shi
  • Publication number: 20190225610
    Abstract: A type of deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereof. The derivatives are compounds of Formula (I) or pharmaceutically acceptable salts thereof. These compounds or salts thereof can be used for treatment or prevention of diseases or illnesses through certain mutant forms of epidermal growth factor receptors, inhibit the growth of various tumor cells effectively, and inhibit other proteases of EGFR and Her families, they can be used for preparing anti-tumor drugs.
    Type: Application
    Filed: September 18, 2017
    Publication date: July 25, 2019
    Inventors: Yongqiang ZHU, Zhaogang LIU, Chao FENG, Shihe HU, Hao CHEN, Enhe BAI, Jie WANG, Jingmiao SHI